Conference item

Guselkumab provides sustained domain-specific and comprehensive efficacy as assessed using composite endpoints in patients with active psoriatic arthritis free

Publication status:: Published

Peer review status:: Reviewed (other)

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Coates, L. C., Ritchlin, C. T., Gossec, L., Helliwell, P., Rahman, P., Hsia, E. C., Kollmeier, A., Xu, X. L., Karyekar, C., Shawi, M., Noel, W., Jiang, Y., Sheng, S., Wang, Y., & Mease, P. J. (2021). Guselkumab provides sustained domain-specific and comprehensive efficacy as assessed using composite endpoints in patients with active psoriatic arthritis free. 80, 781–782.

MLA Style

Coates, L. C., et al. Guselkumab Provides Sustained Domain-Specific and Comprehensive Efficacy as Assessed Using Composite Endpoints in Patients with Active Psoriatic Arthritis Free. BMJ Publishing Group, 2021, pp. 781–82.

Chicago Style

Coates, LC, CT Ritchlin, L Gossec, P Helliwell, P Rahman, EC Hsia, A Kollmeier, et al. 2021. “Guselkumab Provides Sustained Domain-Specific and Comprehensive Efficacy as Assessed Using Composite Endpoints in Patients with Active Psoriatic Arthritis Free.” In , 80:781–82. BMJ Publishing Group.
Share
Print

Access Document

Publisher copy:: 10.1136/annrheumdis-2021-eular.167

Authors

+ Coates, LC More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDORMS
Sub department:: Botnar Research Centre
Role:: Author
ORCID:: 0000-0002-4756-663X

+ Ritchlin, CT More by this author

Role:: Author

+ Gossec, L More by this author

Role:: Author

+ Helliwell, P More by this author

Role:: Author

+ Rahman, P More by this author

Role:: Author

More authors...

Publisher:: BMJ Publishing Group
Journal:: Annals of the Rheumatic Diseases More from this journal
Volume:: 80
Pages:: 781-782
Publication date:: 2021-05-19
Acceptance date:: 2021-04-01
Event title:: European Alliance of Associations for Rheumatology
Event start date:: 2021-06-02
Event end date:: 2021-06-05
DOI:: 10.1136/annrheumdis-2021-eular.167
EISSN:: 1468-2060
ISSN:: 0003-4967

Language:: English
Keywords:: FFR
Pubs id:: 1195824
Local pid:: pubs:1195824
Deposit date:: 2021-10-04

Terms of use

Copyright holder:: Coates et al.
Copyright date:: 2021
Rights statement:: © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP